Heart disease, also known as coronary disease, is the leading cause of death for Canadian women. Increased risk for coronary disease is primarily associated with the process of aging, yet there is also a relationship between heart health and a woman's midlife transition through menopause.
Before menopause a woman's heart and blood vessels seem to have some protection due to her hormones. But when a woman experiences menopause, her levels of estrogen decrease significantly, and as a result, her risk for heart disease increases.
A woman has a reduced rate of heart disease before menopause compared with men her own age. After menopause, however, a woman's rate of heart disease increases considerably, until by the age of 65, her risk is equal to that of her male peers.
For many years researchers believed that hormone therapy (HT) was beneficial for heart health. Medical practitioners routinely prescribed hormone therapy to women as a preventative measure for heart disease.
However, several new important studies, such as the Women's Health Initiative study, have cast significant doubt on this practice.
Recent research has found conclusively that there is no coronary health benefit for women with a history of heart disease, who take estrogen alone, or estrogen plus a progestin. The studies suggest that there is even the possibility of an increased risk for heart disease for women on hormone therapy.
Research has also found that women without a previous history of heart disease may also face an increased risk for heart disease when taking hormone therapy.
The Heart and Stroke Foundation of Canada has issued new recommendations as a result of the latest study data:
The Society of Obstetricians and Gynaecologists of Canada also recommends that HT should not be used for the prevention of heart disease.
Latest Articles
About Us News & Articles Resources Your Health Connect With Us
© 2012 Canadian Women's Health Network.